Clinical Trial Update: Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

The document reports a Phase 1/Phase 2 clinical trial evaluating ZG005 in combination with Gecacitinib in patients with advanced non-small cell lung cancer, cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gecacitinib (Gecacitinib)
• ZG005

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING